Profile data is unavailable for this security.
About the company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.
- Revenue in USD (TTM)7.54bn
- Net income in USD706.00m
- Incorporated1996
- Employees46.00k
- LocationQuest Diagnostics Inc500 Plaza DrSECAUCUS 07094-3619United StatesUSA
- Phone+1 (973) 520-2700
- Fax+1 (302) 655-5049
- Websitehttps://www.questdiagnostics.com/
Mergers & acquisitions
| Acquired company | DGX:NYQ since announced | Transaction value |
|---|---|---|
| Boyce & Bynum Pathology Laboratories-Clinical laboratory services business | 7.50% | -- |
| Marin General Hospital-Outreach Laboratory Service Operations | 11.46% | -- |
| PhenoPath Laboratories PLLC | -5.15% | -- |
| Oxford Immunotec Global PLC-Laboratory Services Business | -5.25% | 170.00m |
| Reprosource Inc | -5.27% | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2019 | 14.68m | 10.93% |
| Macquarie Investment Management Business Trustas of 31 Mar 2019 | 8.05m | 5.99% |
| BlackRock Fund Advisorsas of 31 Mar 2019 | 8.01m | 5.96% |
| SSgA Funds Management, Inc.as of 31 Mar 2019 | 6.39m | 4.75% |
| American Century Investment Management, Inc.as of 31 Mar 2019 | 4.96m | 3.69% |
| Fiduciary Management, Inc.as of 31 Mar 2019 | 4.20m | 3.12% |
| Davis Selected Advisers LPas of 31 Mar 2019 | 3.64m | 2.71% |
| Boston Partners Global Investors, Inc.as of 31 Mar 2019 | 3.03m | 2.26% |
| Victory Capital Management, Inc.(Investment Management)as of 31 Mar 2019 | 2.84m | 2.12% |
| Geode Capital Management LLCas of 31 Mar 2019 | 2.19m | 1.63% |
